Literature DB >> 25617478

Mechanisms of distal axonal degeneration in peripheral neuropathies.

Christopher R Cashman1, Ahmet Höke2.   

Abstract

Peripheral neuropathy is a common complication of a variety of diseases and treatments, including diabetes, cancer chemotherapy, and infectious causes (HIV, hepatitis C, and Campylobacter jejuni). Despite the fundamental difference between these insults, peripheral neuropathy develops as a combination of just six primary mechanisms: altered metabolism, covalent modification, altered organelle function and reactive oxygen species formation, altered intracellular and inflammatory signaling, slowed axonal transport, and altered ion channel dynamics and expression. All of these pathways converge to lead to axon dysfunction and symptoms of neuropathy. The detailed mechanisms of axon degeneration itself have begun to be elucidated with studies of animal models with altered degeneration kinetics, including the slowed Wallerian degeneration (Wld(S)) and Sarm knockout animal models. These studies have shown axonal degeneration to occur through a programmed pathway of injury signaling and cytoskeletal degradation. Insights into the common disease insults that converge on the axonal degeneration pathway promise to facilitate the development of therapeutics that may be effective against other mechanisms of neurodegeneration.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Campylobacter jejuni; Chemotherapy induced peripheral neuropathy; Diabetes; Guillain–Barré syndrome; HIV neuropathy; Mechanisms of neuropathy; Mitochondrial aging; Peripheral neuropathy; Post-infectious neuropathy; Wld(S)

Mesh:

Substances:

Year:  2015        PMID: 25617478      PMCID: PMC4428955          DOI: 10.1016/j.neulet.2015.01.048

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  300 in total

1.  WldS and PGC-1α regulate mitochondrial transport and oxidation state after axonal injury.

Authors:  Kelley C O'Donnell; Mauricio E Vargas; Alvaro Sagasti
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 2.  Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.

Authors:  Xiao-Min Wang; Tanya J Lehky; Joanna M Brell; Susan G Dorsey
Journal:  Cytokine       Date:  2012-04-24       Impact factor: 3.861

3.  Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes.

Authors:  C E Aubert; P-L Michel; P Gillery; S Jaisson; M Fonfrede; F Morel; A Hartemann; O Bourron
Journal:  Diabetes Metab Res Rev       Date:  2014-11       Impact factor: 4.876

Review 4.  FORMIN a link between kinetochores and microtubule ends.

Authors:  Yinghui Mao
Journal:  Trends Cell Biol       Date:  2011-09-13       Impact factor: 20.808

5.  Pathological adaptive responses of Schwann cells to endoplasmic reticulum stress in bortezomib-induced peripheral neuropathy.

Authors:  Yoon Kyung Shin; So Young Jang; Hyun Kyoung Lee; Junyang Jung; Duk Joon Suh; Su-Yeong Seo; Hwan Tae Park
Journal:  Glia       Date:  2010-12       Impact factor: 7.452

6.  Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve.

Authors:  E R Lunn; V H Perry; M C Brown; H Rosen; S Gordon
Journal:  Eur J Neurosci       Date:  1989       Impact factor: 3.386

7.  Differential effects of HIV infected macrophages on dorsal root ganglia neurons and axons.

Authors:  Katrin Hahn; Barry Robinson; Caroline Anderson; Wenxue Li; Carlos A Pardo; Susan Morgello; David Simpson; Avindra Nath
Journal:  Exp Neurol       Date:  2007-07-06       Impact factor: 5.330

8.  Peripheral neuropathy induced by 2',3'-dideoxycytidine. A rabbit model of 2',3'-dideoxycytidine neurotoxicity.

Authors:  T D Anderson; A Davidovich; R Arceo; C Brosnan; J Arezzo; H Schaumburg
Journal:  Lab Invest       Date:  1992-01       Impact factor: 5.662

9.  Complement dependent cytotoxicity of sensory ganglion neurons mediated by the gp120 glycoprotein of HIV-1.

Authors:  S Apostolski; T McAlarney; A P Hays; N Latov
Journal:  Immunol Invest       Date:  1994-01       Impact factor: 3.657

Review 10.  The spectrum of diabetic neuropathies.

Authors:  Jennifer A Tracy; P James B Dyck
Journal:  Phys Med Rehabil Clin N Am       Date:  2008-02       Impact factor: 1.784

View more
  78 in total

Review 1.  Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism.

Authors:  Josiah Gerdts; Daniel W Summers; Jeffrey Milbrandt; Aaron DiAntonio
Journal:  Neuron       Date:  2016-02-03       Impact factor: 17.173

2.  Type-2 diabetes mellitus reduces cortical thickness and decreases oxidative metabolism in sensorimotor regions after stroke.

Authors:  Jennifer K Ferris; Sue Peters; Katlyn E Brown; Katherine Tourigny; Lara A Boyd
Journal:  J Cereb Blood Flow Metab       Date:  2017-04-12       Impact factor: 6.200

3.  Factors associated with distal symmetric polyneuropathies in adult Zambians: A cross-sectional, observational study of the role of HIV, non-antiretroviral medication exposures, and nutrition.

Authors:  Michelle Kvalsund; Takondwa Chidumayo; Johanna Hamel; David Herrmann; Douglas Heimburger; Amanda Peltier; Gretchen Birbeck
Journal:  J Neurol Sci       Date:  2018-02-22       Impact factor: 3.181

4.  Insulin prevents aberrant mitochondrial phenotype in sensory neurons of type 1 diabetic rats.

Authors:  Mohamad-Reza Aghanoori; Darrell R Smith; Subir Roy Chowdhury; Mohammad Golam Sabbir; Nigel A Calcutt; Paul Fernyhough
Journal:  Exp Neurol       Date:  2017-08-10       Impact factor: 5.330

Review 5.  Roles of palmitoylation in axon growth, degeneration and regeneration.

Authors:  Sabrina M Holland; Gareth M Thomas
Journal:  J Neurosci Res       Date:  2017-02-02       Impact factor: 4.164

6.  Correlation Between Daam2 Expression Changes and Demyelination in Guillain-Barre Syndrome.

Authors:  Quanquan Cui; Peng Xie
Journal:  Cell Mol Neurobiol       Date:  2015-08-21       Impact factor: 5.046

Review 7.  Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas.

Authors:  Estela Area-Gomez; Cristina Guardia-Laguarta; Eric A Schon; Serge Przedborski
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

Review 8.  Gene Therapy Strategies to Restore ER Proteostasis in Disease.

Authors:  Vicente Valenzuela; Kasey L Jackson; Sergio P Sardi; Claudio Hetz
Journal:  Mol Ther       Date:  2018-04-07       Impact factor: 11.454

9.  Evidence for dying-back axonal degeneration in age-associated skeletal muscle decline.

Authors:  Tae Chung; Jae Sung Park; Sangri Kim; Nataly Montes; Jeremy Walston; Ahmet Höke
Journal:  Muscle Nerve       Date:  2017-04-01       Impact factor: 3.217

Review 10.  Hepatitis C virus and neurological damage.

Authors:  Shilu Mathew; Muhammed Faheem; Sara M Ibrahim; Waqas Iqbal; Bisma Rauff; Kaneez Fatima; Ishtiaq Qadri
Journal:  World J Hepatol       Date:  2016-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.